A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia

Sonia Christian, Saad Arain, Pritesh Patel, Irum Khan, Gregory S. Calip, Vaibhav Agrawal, Karen Sweiss, Shawn Griffin, Kirk Cahill, Heiko Konig, Aysenur Esen, Ardaman Shergill, Olatoyosi Odenike, Wendy Stock, John G. Quigley*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science